Company Profiles

driven by the PitchBook Platform

Ai2

Ai2
2005 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Grant LATEST DEAL TYPE
$232K LATEST DEAL AMOUNT
3 INVESTORS
Description

Developer of human protein-like substances designed to prevent infection. The company's protein-like substances inhibit bacteria, fungi and viruses, enabling health care providers to use it in medical devices like urinary catheters and stents as well as in wound dressings and consumer products.

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • The Incubator Building
  • 48 Grafton Street
  • Manchester M13 9XX
  • England

+44 0161 000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Ai2’s full profile, request a free trial.

Ai2 Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 12-Aug-2013 $232K 00.000 Completed Generating Revenue
5. Grant 25-May-2012 00000 00.000 Completed Generating Revenue
4. Later Stage VC (Series B) 06-Jan-2012 00.000 00.000 00.000 Completed Generating Revenue
3. Later Stage VC (Series A) 08-Feb-2010 00000 00000 00.000 Completed Generating Revenue
2. Early Stage VC 01-Dec-2009 $406K $406K Completed Startup
1. Grant 01-Sep-2009 $163K Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Ai2 Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 00,000 00.000000 000.00 000.00 00 000.00 00.000
Series A2 0,000 00.000000 000.0 000.0 00 000.0 0.000
Series A1 0,000 00.000000 00.00 00.00 00 00.00 00.000
Pref Penny 499 $0.015504 $0.02 $0.02 1x $0.02 0.82%
Pref 284,892 $0.015504 $1.55 $1.55 1x $1.55 469.8%
To view this company’s complete Cap Table, request access »

Ai2 Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Spark Impact Corporate Venture Capital Minority 000 0000 000000 0
The North West Fund Venture Capital Minority 000 0000 000000 0
MTI Partners Venture Capital Minority 000 0000 000000 0

Ai2 Executive Team (4)

Name Title Board
Seat
Contact
Info
Duncan Henderson Ph.D Chief Executive Officer
Joannah Stretton Financial Controller
Curtis Dobson Ph.D Co-Founder, Board Member & Non-Executive Director

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »

Ai2 Board Members (6)

Name Representing Role Since Contact
Info
Andrew Round Ph.D Self Board Member 000 0000
Curtis Dobson Ph.D Ai2 Co-Founder, Board Member & Non-Executive Director 000 0000
David Holbrook MTI Partners Board Member 000 0000
Kevin Dsilva Ai2 Board Member 000 0000
Kevin D'Silva Self Non-Executive Chairman 000 0000
You’re viewing 5 of 6 board members. Get the full list »